Taking the opportunity of COVID testing to screen vulnerable populations for hepatitis B, hepatitis C, syphilis, and human immunodeficiency virus in Central Brazil
- PMID: 40644428
- PMCID: PMC12250198
- DOI: 10.1371/journal.pone.0325859
Taking the opportunity of COVID testing to screen vulnerable populations for hepatitis B, hepatitis C, syphilis, and human immunodeficiency virus in Central Brazil
Abstract
Vulnerable populations were disproportionally affected by the coronavirus disease 2019 (COVID-19) pandemic and its peak periods disrupted progress toward the control and prevention of sexually transmitted infections (STIs). This study aimed to investigate the prevalence and factors associated with hepatitis B virus (HBV), hepatitis C virus (HCV), syphilis, and human immunodeficiency virus (HIV) among socio-economically vulnerable populations during the COVID-2019 pandemic in Goiania, Central Brazil. A total of 627 individuals, including lesbian, gay, bisexual, and transgender people, homeless individuals, waste recyclable collectors, and immigrants/refugees, were tested for these infections. Multiple Poisson regression models were used to analyze the factors associated with each outcome. HBV exposure markers were found in 16.1% of participants, antibodies against HCV (anti-HCV) in 1.9%, syphilis in 17.2%, and antibodies against HIV (anti-HIV) in 6.1%. Thirty-two individuals exhibited serological evidence of active syphilis, whereas HBV deoxyribonucleic acid and HCV ribonucleic acid were detected in six and two individuals, respectively. Increased age was statistically associated with HCV, HBV, and syphilis; identifying as LGBT and reporting a history of STIs was associated with syphilis and HIV. Illicit drug use was associated with HCV and HIV, whereas being an immigrant/refugee or engaging in transactional sex was linked to HBV. Homelessness and reporting a higher number of sexual partners in the previous month were associated with syphilis. High prevalence rates of these infections were identified, with many participants showing evidence of active infections, increasing the risk of transmission. Specific risk behaviors were associated with each infection, emphasizing the need to tailor prevention strategies to address these behaviors effectively.
Copyright: © 2025 Silva Filho et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
NO authors have competing interests.
Similar articles
-
Prevalence of human immunodeficiency virus, syphilis, and hepatitis B and C virus infections in pregnant women: a systematic review and meta-analysis.Clin Microbiol Infect. 2023 Aug;29(8):1000-1007. doi: 10.1016/j.cmi.2023.03.002. Epub 2023 Mar 13. Clin Microbiol Infect. 2023. PMID: 36921717
-
NIH Consensus Statement on Management of Hepatitis C: 2002.NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. NIH Consens State Sci Statements. 2002. PMID: 14768714
-
Population-based interventions for reducing sexually transmitted infections, including HIV infection.Cochrane Database Syst Rev. 2004;(2):CD001220. doi: 10.1002/14651858.CD001220.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001220. doi: 10.1002/14651858.CD001220.pub3. PMID: 15106156 Updated.
-
Prevalence and factors associated with hepatitis B and C virus infections among female Sex workers in Ethiopia: Results of the national biobehavioral Survey, 2020.PLoS One. 2022 Dec 30;17(12):e0269510. doi: 10.1371/journal.pone.0269510. eCollection 2022. PLoS One. 2022. PMID: 36584042 Free PMC article.
-
Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001220. doi: 10.1002/14651858.CD001220.pub3. Cochrane Database Syst Rev. 2011. PMID: 21412869
References
-
- WHO. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually traansmitted infections for the period 2022-2030. Geneva: World Health Organization; 2022. p. 126.
-
- WHO. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization; 2021. p. 592. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical